CA2329175A1 - Improvements in or relating to contrast agents - Google Patents

Improvements in or relating to contrast agents Download PDF

Info

Publication number
CA2329175A1
CA2329175A1 CA002329175A CA2329175A CA2329175A1 CA 2329175 A1 CA2329175 A1 CA 2329175A1 CA 002329175 A CA002329175 A CA 002329175A CA 2329175 A CA2329175 A CA 2329175A CA 2329175 A1 CA2329175 A1 CA 2329175A1
Authority
CA
Canada
Prior art keywords
gas
combined preparation
dispersed
composition
diffusible component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002329175A
Other languages
English (en)
French (fr)
Inventor
Sigmund Frigstad
Pal Rongved
Jonny Ostensen
Alan Cuthbertson
Helge Tolleshaug
Morten Eriksen
Roald Skurtveit
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare AS
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2329175A1 publication Critical patent/CA2329175A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0028—Disruption, e.g. by heat or ultrasounds, sonophysical or sonochemical activation, e.g. thermosensitive or heat-sensitive liposomes, disruption of calculi with a medicinal preparation and ultrasounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasonic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasonic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Acoustics & Sound (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Light Receiving Elements (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002329175A 1998-04-22 1999-04-22 Improvements in or relating to contrast agents Abandoned CA2329175A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9808599.6 1998-04-22
GBGB9808599.6A GB9808599D0 (en) 1998-04-22 1998-04-22 Improvements in or realting to contrast agents
PCT/GB1999/001221 WO1999053963A1 (en) 1998-04-22 1999-04-22 Improvements in or relating to contrast agents

Publications (1)

Publication Number Publication Date
CA2329175A1 true CA2329175A1 (en) 1999-10-28

Family

ID=10830802

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002329175A Abandoned CA2329175A1 (en) 1998-04-22 1999-04-22 Improvements in or relating to contrast agents

Country Status (17)

Country Link
US (1) US20040146462A1 (cg-RX-API-DMAC7.html)
EP (1) EP1073473B1 (cg-RX-API-DMAC7.html)
JP (1) JP2002512206A (cg-RX-API-DMAC7.html)
KR (1) KR20010042915A (cg-RX-API-DMAC7.html)
CN (1) CN1306442A (cg-RX-API-DMAC7.html)
AT (1) ATE375806T1 (cg-RX-API-DMAC7.html)
AU (1) AU3617299A (cg-RX-API-DMAC7.html)
BR (1) BR9909822A (cg-RX-API-DMAC7.html)
CA (1) CA2329175A1 (cg-RX-API-DMAC7.html)
DE (1) DE69937341D1 (cg-RX-API-DMAC7.html)
GB (1) GB9808599D0 (cg-RX-API-DMAC7.html)
HU (1) HUP0102878A3 (cg-RX-API-DMAC7.html)
IL (1) IL139147A0 (cg-RX-API-DMAC7.html)
NO (1) NO20005250L (cg-RX-API-DMAC7.html)
PL (1) PL343464A1 (cg-RX-API-DMAC7.html)
WO (1) WO1999053963A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200005789B (cg-RX-API-DMAC7.html)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804162A (en) * 1995-06-07 1998-09-08 Alliance Pharmaceutical Corp. Gas emulsions stabilized with fluorinated ethers having low Ostwald coefficients
DE10119522A1 (de) * 2001-04-20 2002-12-05 Innovacell Biotechnologie Gmbh Herstellung und Anwendung einer Suspensionszusammensetzung mit einem Ultraschall-Kontrastmittel
CA2504668A1 (en) 2002-11-29 2004-06-17 Amersham Health As Ultrasound triggering method
US20070128117A1 (en) * 2003-02-04 2007-06-07 Bracco International B.V. Ultrasound contrast agents and process for the preparation thereof
EP1590006B1 (en) 2003-02-04 2010-09-08 Bracco Suisse SA Ultrasound contrast agents and process for the preparation thereof
ES2531751T3 (es) * 2003-12-22 2015-03-18 Bracco Suisse Sa Montaje de microvesícula rellena de gas con componente activo para imagenología de contraste
CA2547024C (en) * 2003-12-22 2013-12-17 Bracco Research Sa Gas-filled microvesicle assembly for contrast imaging
WO2006018433A1 (en) 2004-08-18 2006-02-23 Bracco Research Sa Gas-filled microvesicles composition for contrast imaging
US8153435B1 (en) 2005-03-30 2012-04-10 Tracer Detection Technology Corp. Methods and articles for identifying objects using encapsulated perfluorocarbon tracers
CN100453050C (zh) * 2005-09-21 2009-01-21 北京市肿瘤防治研究所 提高超声造影图像分辨力的方法和超声造影成像仪
US20080255266A1 (en) * 2007-04-10 2008-10-16 Gc Corporation Dental paste composition having x-ray imaging property
JP4279328B2 (ja) * 2007-05-07 2009-06-17 株式会社日立製作所 超音波撮像システム
WO2009097277A1 (en) * 2008-02-01 2009-08-06 Trustees Of Boston University Cationic contrast agents and methods of use thereof
WO2009134435A2 (en) * 2008-05-02 2009-11-05 Celsense Inc. Compositions and methods for producing emulsions for nuclear magnetic resonance techniques and other applications
US10058837B2 (en) 2009-08-28 2018-08-28 The Trustees Of Columbia University In The City Of New York Systems, methods, and devices for production of gas-filled microbubbles
DE102011005444A1 (de) * 2011-03-11 2012-09-13 Innora Gmbh Festes, negatives Röntgenkontrastmittel zur Darstellung des Gastrointestinaltraktes
PT3049117T (pt) * 2013-09-27 2022-10-19 Phoenix Solutions As Libertação de medicamentos mediada por ultrassons
SG11201604978QA (en) * 2013-12-19 2016-07-28 Bayer Pharma AG Substituted piperidinyl-tetrahydroquinolines and their use as alpha-2c adrenoreceptor antagonists
WO2019014070A1 (en) * 2017-07-09 2019-01-17 The Board Of Trustees Of The Leland Stanford Junior University ULTRASOUND IMAGING COMPRISING A SPECTRAL COMPOSITION FOR TAVELURE REDUCTION
AU2018329237A1 (en) * 2017-09-07 2020-03-19 Imbiotechnologies Ltd. Sono-responsive embolic agents
CN108586300B (zh) * 2018-03-28 2020-03-17 成都福柯斯医药技术有限公司 一种s-碘化丁酰硫代胆碱的合成方法
AU2020371044B2 (en) 2019-10-25 2025-10-30 Exact Therapeutics As Treatment of pancreatic cancer
GB2595513B (en) * 2020-05-29 2023-03-29 Act Therapeutics Ltd Treatment of infections
US11801058B2 (en) * 2021-03-04 2023-10-31 Accumedical Beijing Ltd. Liquid embolic compositions
GB2605422B (en) 2021-03-31 2025-04-30 Act Therapeutics Ltd Treatment of the central nervous system
GB2629999B (en) 2021-04-21 2025-03-26 Act Therapeutics Ltd Enhancement of treatment with immunotherapeutic agents
CN113598820B (zh) * 2021-08-18 2025-09-23 南京超微影医疗科技有限公司 超声成像方法及装置
EP4261786A1 (en) * 2022-03-28 2023-10-18 Tata Consultancy Services Limited Methods and system for low dose x ray computed tomography perfusion imaging
NO20221187A1 (en) 2022-11-04 2024-05-06 Exact Therapeutics As Method and system for calculating a point estimate of an ultrasound dose
CN116271187B (zh) * 2023-03-21 2025-07-04 湖北科技学院 双模态显影温敏Pickering乳液介入栓塞材料及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5228446A (en) * 1989-12-22 1993-07-20 Unger Evan C Gas filled liposomes and their use as ultrasonic contrast agents
US5776429A (en) * 1989-12-22 1998-07-07 Imarx Pharmaceutical Corp. Method of preparing gas-filled microspheres using a lyophilized lipids
US5580575A (en) * 1989-12-22 1996-12-03 Imarx Pharmaceutical Corp. Therapeutic drug delivery systems
US5716597A (en) * 1993-06-04 1998-02-10 Molecular Biosystems, Inc. Emulsions as contrast agents and method of use
ES2231775T5 (es) * 1993-07-30 2011-02-02 Imcor Pharmaceutical Co. Composición de microburbujas estabilizadas para ecografía.
NO940711D0 (no) * 1994-03-01 1994-03-01 Nycomed Imaging As Preparation of gas-filled microcapsules and contrasts agents for diagnostic imaging
US5846517A (en) * 1996-09-11 1998-12-08 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a renal contrast agent and a vasodilator
MXPA99003664A (es) * 1996-10-21 2002-06-11 Nycomed Imaging As Mejoras relacionadas con agentes de contraste.
ES2206689T3 (es) * 1996-10-28 2004-05-16 Amersham Health As Agentes de contraste.
EP0991427A2 (en) * 1996-10-28 2000-04-12 Marsden, John Christopher Improvements in or relating to diagnostic/therapeutic agents
WO1998018498A2 (en) * 1996-10-28 1998-05-07 Marsden, John, Christopher Improvements in or relating to diagnostic/therapeutic agents

Also Published As

Publication number Publication date
HUP0102878A2 (hu) 2002-03-28
CN1306442A (zh) 2001-08-01
ZA200005789B (en) 2001-07-30
BR9909822A (pt) 2000-12-19
NO20005250D0 (no) 2000-10-19
EP1073473B1 (en) 2007-10-17
JP2002512206A (ja) 2002-04-23
DE69937341D1 (de) 2007-11-29
HUP0102878A3 (en) 2002-12-28
IL139147A0 (en) 2001-11-25
US20040146462A1 (en) 2004-07-29
NO20005250L (no) 2000-12-18
WO1999053963A1 (en) 1999-10-28
ATE375806T1 (de) 2007-11-15
EP1073473A1 (en) 2001-02-07
PL343464A1 (en) 2001-08-13
GB9808599D0 (en) 1998-06-24
KR20010042915A (ko) 2001-05-25
AU3617299A (en) 1999-11-08

Similar Documents

Publication Publication Date Title
EP1073473B1 (en) Improvements in or relating to contrast agents
US6375931B2 (en) Contrast agents
AU2003210631B2 (en) Novel targeted compositions for diagnostic and therapeutic use
AU2003210631A1 (en) Novel targeted compositions for diagnostic and therapeutic use
EP0977599B1 (en) Contrast agents comprising an azeotropic mixture of two gases for ultrasound investigations
EP1073474A1 (en) Improvements in or relating to contrast agents
US20040131547A1 (en) Contrast agents
EP1079865B1 (en) Ultrasound contrast agent dispersions comprising gas and destabilising agent
US20040170564A1 (en) Ultrasound contrast agent dispersions comprising gas and destabilising agent
MXPA00010301A (en) Improvements in or relating to contrast agents
CZ20003896A3 (cs) Kombinovaný prostředek

Legal Events

Date Code Title Description
FZDE Discontinued